https://www.alkermes.com/
Alkermes – A Global Biopharmaceutical Company
Alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines in the field of neuroscience.
alkermesglobalbiopharmaceuticalcompany
https://www.prnewswire.com/news-releases/alkermes-to-take-part-in-svb-leerink-10th-annual-global-healthcare-conference-301231128.html
Alkermes to Take Part in SVB Leerink 10th Annual Global Healthcare Conference
/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a virtual fireside chat at the SVB Leerink Global Healthcare...
take part
https://crueltyfreeinvesting.org/companies/alkermes-plc/
Alkermes plc - Cruelty Free Investing
Oct 17, 2025 - Alkermes plc is a biopharmaceutical company that focuses on central nervous system (CNS) diseases. Alkermes has more than 20 commercial drug products and...
cruelty freealkermesplcinvesting
https://www.biospace.com/alkermes-to-take-part-in-svb-leerink-10th-annual-global-healthcare-conference
Alkermes to Take Part in SVB Leerink 10th Annual Global Healthcare Conference - BioSpace
Feb 18, 2021 - Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a virtual fireside chat at the SVB Leerink Global Healthcare Conference on...
https://www.biopharmadive.com/news/alkermes-separate-mural-cancer-oncology-business/699839/
Alkermes separates cancer drug business as new company Mural | BioPharma Dive
Now independent Mural Oncology will focus on advancing a pipeline of engineered cytokines for cancer, while Alkermes has recast itself as a “pure-play”...
cancer drugas newalkermesseparatesbusiness
https://shareholdersfoundation.com/alkermes-inc
Alkermes, Inc | shareholdersfoundation.com
alkermesinc
https://kbjr.marketminute.com/quote/NQ:ALKS/faq
Frequently Asked Questions about Alkermes plc - Ordinary Shares (Nasdaq:ALKS) | KBJR/CBS3
See our most frequently asked questions about Alkermes plc - Ordinary Shares (Nasdaq:ALKS)
frequently asked questions
https://manufacturingchemist.com/alkermes-reports-third-quarter-2015-financial-results-113184
Alkermes reports third quarter 2015 financial results
Commercial launch of Aristada underway following FDA Approval for the treatment of Schizophrenia on 5 October 5, 2015
third quarteralkermesreportsfinancialresults
https://mavefund.com/company/ALKS
Alkermes Plc (ALKS) Stock Forecast, Valuation & Analysis | Mavefund
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in...
stock forecastvaluation analysisalkermesplcalks
https://it.marketscreener.com/quotazioni/azione/ALKERMES-PLC-13323547/derivati-turbos/
Alkermes plc: turbo Azione Alkermes plc | ALKS | MarketScreener Italia
Alkermes plc: elenco dei tTurbo Certificates (Call e Put) Azione Alkermes plc | ALKS | Nasdaq
alkermesplcturboazionealks
https://www.clinicaltrialsarena.com/news/newsamylin-alkermes-diabetes-drug-wins-fda-approval/
Amylin and Alkermes diabetes drug wins FDA approval - Clinical Trials Arena
Jan 29, 2012 - Amylin Pharmaceuticals and Alkermes have announced that the US Food and Drug Administration (FDA) has approved Bydureon (exenatide extended-release for...
fda approvalclinical trialsamylinalkermesdiabetes
https://psychiatryeditorial.com/alkermes-announces-positive-results-from-study-of-alks-5461-for-treatment-of-major-depressive-disorder-2/
Alkermes Announces Positive Results From Study of ALKS 5461 for Treatment of Major Depressive...
https://www.alkermes.com/news/tom-harvey-retirement-2025
Tom Harvey: Reflections on 20 Years at Alkermes | Alkermes
Tom Harvey shares his perspective on his time at Alkermes as he prepares to retire.
tomharveyreflectionsyearsalkermes
https://www.prnewswire.com/news-releases/alkermes-to-present-at-the-8th-annual-svb-leerink-global-healthcare-conference-300798898.html
Alkermes to Present at the 8th Annual SVB Leerink Global Healthcare Conference
/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that its Chief Executive Officer, Richard Pops, will participate in a fireside chat at the SVB...
at the
https://www.nationalinvestornetwork.com/company-profile/alkermes-plc?hsLang=en
Alkermes plc
alkermesplc